Instructions for Submitting Data Utilization Plan
페이지 정보
본문
.
Please send the attached file, **Data_Utilization_Plan.docx**, to the administrator's email . After the administrator reviews it, your membership level will be adjusted accordingly.
**Email Submission Instructions:**
* **Email Subject**: [MDAISS] Data Utilization Plan Submission
* **Recipient Email**: Send to mcastenosis@gmail.com, smcstrokeml@gmail.com, niy0404@skku.edu
* **From Email**: Use the institutional email address you entered during registration
* **Email Content**: Include your registered ID in the email body
**Clinical Information:**
```
Site_Serial No., Sex, Age, ER time, Height, Weight, SBP, DBP, HR, Last normal time, First abnormal time, HTN, DM, Dyslipidemia, PAOD, CAD, Afib, Prev_stroke, Active cancer, Smoking, Persistent AF, Paroxysmal AF, Left atrial thrombus, Left ventricular thrombus, Sick sinus syndrome, Atrial flutter, Recent MI, Rheumatic valvular disease, Mitral stenosis, Prosthetic valve, Chronic MI with low EF(<30%), Dilated CMP, NBTE, Fibroelastoma, Left atrial myxoma, Mitral annulus calcification, Patent foramen ovale, Atrial septal aneurysm, PFO with ASA, Left ventricular aneurysm, Left atrial smoke, Complex aortic atheroma, htx_Aspirin, htx_Clopidogrel, htx_Cilostazol, htx_Trifluzal, htx_Ticlopidine, htx_Heparin, htx_Warfarin, htx_LMWH, htx_Thrombin inhibitor, htx_HTN, htx_DM, htx_Dyslipidemia(statin), htx_Dyslipidemia(non-statin), atx_Aspirin, atx_Clopidogrel, atx_Cilostazol, atx_Trifluzal, atx_Ticlopidine, atx_Heparin, atx_Warfarin, atx_LMWH, atx_Tarombin inhibitor, atx_HTN, atx_DM, atx_Dyslipidemia(statin), atx_Dyslipidemia(non-statin), IV-tPA, IA thrombectomy, IA puncture time, Post IA TICI grade, Stenting_ICAS, Carotid artery stenting, CEA, Bypass, Craniectomy, PFO-closure, LAA-closure, dtx_Aspirin, dtx_Clopidogrel, dtx_Cilostazol, dtx_Trifluzal, dtx_Ticlopidine, dtx_Heparin, dtx_Warfarin, dtx_LMWH, dtx_Tarombin inhibitor, dtx_HTN, dtx_DM, dtx_Dyslipidemia(statin), dtx_Dyslipidemia(non-statin), TOAST, Initial NIHSS, Initial mRS, 7day or discharge NIHSS, 7day or discharge mRS, END, END_date, discharge date, dIscharge state, expired_cause, Hb, Hct, WBC, Platelet count, ESR, CRP, TSH, Free T4, Glucose at ER, Fasting glucose, D-dimer, Uric acid, HbA1C, CK-MB, Total Cholesterol, TG, HDL, LDL, PT(INR), aPTT, FDP, Homocysteine, AST, ALT, Bilirubin, Free fatty acid, Creatinine serum, NT-proBNP, ProBNP
```
Thank you.
첨부파일
- Data Utilization Plan.docx (31.5K) 10회 다운로드 | DATE : 2024-11-01 12:43:12
- Data Use Authorization Procedure Guide.pdf (53.2K) 6회 다운로드 | DATE : 2024-11-01 12:43:12
- 다음글공지사항 테스트 22.04.01
댓글목록
등록된 댓글이 없습니다.

